These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29712703)

  • 1. Response by Packer to Letter Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchange Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Packer M
    Circulation; 2018 May; 137(18):1981-1982. PubMed ID: 29712703
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
    Packer M
    Circulation; 2017 Oct; 136(16):1548-1559. PubMed ID: 29038209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Gazmuri RJ; Karmazyn M
    Circulation; 2018 May; 137(18):1979-1980. PubMed ID: 29712702
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes Mellitus and Heart Failure.
    Lehrke M; Marx N
    Am J Med; 2017 Jun; 130(6S):S40-S50. PubMed ID: 28526183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.
    Jorsal A; Wiggers H; McMurray JJV
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):117-135. PubMed ID: 29407047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Mellitus and Heart Failure.
    Lehrke M; Marx N
    Am J Cardiol; 2017 Jul; 120(1S):S37-S47. PubMed ID: 28606342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes.
    Packer M
    Diabetes Obes Metab; 2018 Apr; 20(4):800-811. PubMed ID: 29227582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes and heart failure : Update 2017].
    Schütt K; Marx N
    Herz; 2017 May; 42(3):329-340. PubMed ID: 28396903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus.
    Trang A; Aguilar D
    Curr Heart Fail Rep; 2017 Dec; 14(6):445-453. PubMed ID: 29094264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure.
    Verbrugge FH
    Curr Heart Fail Rep; 2017 Aug; 14(4):275-283. PubMed ID: 28647919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congestive heart failure and diabetes mellitus: an intricated relationship].
    De Flines J; Scheen AJ
    Rev Med Liege; 2007 Feb; 62(2):112-7. PubMed ID: 17461301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis.
    Rajasekeran H; Lytvyn Y; Cherney DZ
    Kidney Int; 2016 Mar; 89(3):524-6. PubMed ID: 26880444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-hydrogen exchange system in LLC-PK1 epithelium.
    Moran A
    Am J Physiol; 1987 Jan; 252(1 Pt 1):C63-7. PubMed ID: 3028147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic Heart Failure and Diabetes Mellitus: Pathogenesis and Possibilities of Treatment].
    Obrezan AG; Kulikov NV
    Kardiologiia; 2018 Jul; 58(7):85-94. PubMed ID: 30081813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response by Packer to Letter Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
    Packer M
    Circulation; 2017 Apr; 135(15):e892-e893. PubMed ID: 28396385
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of diabetes on Na(+)-H+ exchange by single isolated hepatocytes.
    Boyarsky G; Rosenthal N; Barrett E; Boron WF
    Am J Physiol; 1991 Jan; 260(1 Pt 1):C167-75. PubMed ID: 1846269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.
    Karmazyn M; Sostaric JV; Gan XT
    Drugs; 2001; 61(3):375-89. PubMed ID: 11293648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit.
    DeFilippis EM; Givertz MM
    Curr Heart Fail Rep; 2016 Jun; 13(3):111-8. PubMed ID: 27188181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
    Packer M
    Diabetes Obes Metab; 2018 Jun; 20(6):1361-1366. PubMed ID: 29359851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytes.
    Gan XT; Gong XQ; Xue J; Haist JV; Bai D; Karmazyn M
    Cardiovasc Res; 2010 Jan; 85(1):79-89. PubMed ID: 19687166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.